NZ505449A - A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis - Google Patents

A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis

Info

Publication number
NZ505449A
NZ505449A NZ505449A NZ50544900A NZ505449A NZ 505449 A NZ505449 A NZ 505449A NZ 505449 A NZ505449 A NZ 505449A NZ 50544900 A NZ50544900 A NZ 50544900A NZ 505449 A NZ505449 A NZ 505449A
Authority
NZ
New Zealand
Prior art keywords
milk
mammal
supresses
administering
yield
Prior art date
Application number
NZ505449A
Inventor
Tim Mackle
Dale E Bauman
Original Assignee
Tim Mackle
Dale E Bauman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tim Mackle, Dale E Bauman filed Critical Tim Mackle
Priority to NZ505449A priority Critical patent/NZ505449A/en
Priority to AU2001267960A priority patent/AU2001267960B2/en
Priority to AU6796001A priority patent/AU6796001A/en
Priority to PCT/NZ2001/000123 priority patent/WO2002000034A1/en
Priority to ARP010103102A priority patent/AR029691A1/en
Publication of NZ505449A publication Critical patent/NZ505449A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2230/00Aspects relating to animal feed or genotype
    • A23C2230/10Animal milk with modified composition due to a specific feed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Described is an exvivo cell system for use in vivo expression of an interferon-beta protein, the system comprising: a cell of a mammal; and a vector contained therein having an interferon beta polynucleotide sequence for encoding interferon beta protein and allowing its expression.
NZ505449A 2000-06-28 2000-06-28 A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis NZ505449A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
NZ505449A NZ505449A (en) 2000-06-28 2000-06-28 A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis
AU2001267960A AU2001267960B2 (en) 2000-06-28 2001-06-26 Altering milk production and milk components
AU6796001A AU6796001A (en) 2000-06-28 2001-06-26 Altering milk production and milk components
PCT/NZ2001/000123 WO2002000034A1 (en) 2000-06-28 2001-06-26 Altering milk production and milk components
ARP010103102A AR029691A1 (en) 2000-06-28 2001-06-28 MODIFICATION OF MILK PRODUCTION AND MILK COMPONENTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ505449A NZ505449A (en) 2000-06-28 2000-06-28 A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis

Publications (1)

Publication Number Publication Date
NZ505449A true NZ505449A (en) 2003-01-31

Family

ID=19927964

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ505449A NZ505449A (en) 2000-06-28 2000-06-28 A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis

Country Status (4)

Country Link
AR (1) AR029691A1 (en)
AU (2) AU6796001A (en)
NZ (1) NZ505449A (en)
WO (1) WO2002000034A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004015471D1 (en) * 2003-05-06 2008-09-11 Virtus Nutrition Llc CALCIUM SALT OF TRANS AND MULTIPLE UNSATURATED FATTY ACIDS
WO2008066380A2 (en) * 2006-11-27 2008-06-05 Friesland Brands B.V. Process for the preparation of powdered oils

Also Published As

Publication number Publication date
WO2002000034A1 (en) 2002-01-03
AR029691A1 (en) 2003-07-10
AU2001267960B2 (en) 2004-12-23
AU6796001A (en) 2002-01-08

Similar Documents

Publication Publication Date Title
ES2102196T3 (en) PERIPHERIALIZATION OF HEMATOPOYETIC PLURIPOTENTIAL CELLS.
UA93349C2 (en) Method of stabilizing interferon monomeric protein
EP0092574A4 (en) Oligonucleotide therapeutic agent and methods of making same.
DK0828758T3 (en) Chimeric adipose pro-GRF analogs with enhanced biological potency
MY102806A (en) Human interleukin-3 and muteins thereof
ATE88352T1 (en) HUMAN RELAXIN PREPARATIVE.
HK206196A (en) Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complex
IL72985A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
IL81221A0 (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them
PT83255A (en) Process for the preparation of polypeptides and characteristic antibodies of papillomavirus and diagnostic method thereto
IT8483359A0 (en) PROCEDURE TO OBTAIN THE PREPARATION OF PROTEIN CONCENTRATES AND NUTRIENTS FROM ANIMAL BLOOD.
NZ505449A (en) A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis
WO1989000582A3 (en) Human granulocyte-macrophage colony stimulating factor and muteins thereof
NZ503401A (en) Use of interferon-beta (IFN-B) genes for the treatment of cancer
ZA978503B (en) Vertebrate smoothened proteins
EP0316818A3 (en) Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
EP0282018A3 (en) Process for isolating basal membrane proteins from human or animal tissues
HUP0001057A2 (en) Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
ATE266094T1 (en) PRODUCTION OF THE PROTEIN INGAP WITH HIGH EXPRESSION RATE
SE8804607L (en) WATER FORMULATIONS CONTAINING A PIPERIDINYLYCYLOPENTYLPHENONIC ACID DERIVATIVE
DE69027441D1 (en) Ribozymenhemmer
JPS6455143A (en) Production of milk powder for nursing which is endowed with phylactic ability
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
Kovářů et al. Inhibitory Action of Pig Alpha-Fetoprotein Early Activated Thymocyte Surface trohugh Na+, K+-Adenosinetriphosphatase
BG44056A1 (en) Feromonic snare for acleris phombana den.&schiff. (lepidoptera:tortricidae)

Legal Events

Date Code Title Description
PSEA Patent sealed
ASS Change of ownership

Owner name: NEW ZEALAND DAIRY BOARD, NZ

Free format text: OLD OWNER(S): DALE E BAUMAN; TIM MACKLE

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed